GALAPAGOS NV |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.37 EUR | 0.00% |
|
0.00% | 0.00% |
| 31/05 | Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment | MT |
| 31/05 | Galapagos, Adaptimmune Therapeutics Team Up to Evaluate Head and Neck Cancer Drug | MT |
b4f81884.R_i_Nc560NpbAhz3ycDGabIDGlyZtFi4BgMCwbNIZxE.Iqrbb6ssp5A3Z1aHho2oE_kwVB7D1h2AQDUv8cIFUmAki9VhqhTptTJRJA~2be6b9b22d2af4f0790b9e5f230ede76
